Johns Hopkins engineers have created a new optical tool that could improve cancer imaging. Their approach, called SPECTRA, uses tiny nanoprobes that light up when they attach to aggressive cancer ...

Imaging ovarian cancer and its metastases is important for diagnosis, staging and follow-up. The authors of this Review describe functional imaging techniques that are currently used in the ...

Methods: Between 01/2008 and 04/2010, 34 patients with a localized prostate cancer (T1-T3, N0) were prospectively enrolled in the ERIS trial. All patients underwent high dose IMRT with or without long ...

Imaging bone metastases from prostate cancer presents several challenges. The lesions are usually sclerotic and appear late on the conventional X-ray. Bone scintigraphy is the mainstay of lesion ...

May 7, 2003 — Magnetic resonance imaging (MRI) was better than scintigraphy or positron emission tomography (PET) for whole body detection of skeletal metastases, according to the results of a ...

Concordance of FDG-PET scan and MRI- spectroscopy in primary and metastatic intracranial tumors. JCO 22 , 1551-1551 (2004). DOI: 10.1200/jco.2004.22.90140.1551 ...

October 3, 2007 — Researchers say their work is adding weight to the argument that magnetic resonance spectroscopy should be added to routine breast magnetic resonance imaging (MRI) exams. "This ...

The new tool— combining Raman spectroscopy and machine learning—introduces the Ramanome-based Metastasis Index (RMI), offering an innovative means of diagnosing and managing cancer.

Combining magnetic resonance (MR)-guided focused ultrasound with microbubbles and immune checkpoint inhibitors (ICIs) could transform non-small cell lung cancer (NSCLC) treatment by reducing ...

Raman spectroscopy is already used in neurosurgery, but in a more invasive and less precise manner. "Studies have been conducted on its use during brain tumor surgery in patients," Valiente notes.

The team found that, unlike CT or MRI scans that can indicate the presence of a tumor but not the specific molecular signatures that can alert physicians to current or impending metastasis, SPECTRA ...